Patents by Inventor Christopher Read

Christopher Read has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4526783
    Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria.
    Type: Grant
    Filed: June 9, 1981
    Date of Patent: July 2, 1985
    Assignee: Beecham Group p.l.c.
    Inventors: Martin Cole, Thomas T. Howarth, Christopher Reading
  • Patent number: 4525353
    Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria.
    Type: Grant
    Filed: February 26, 1982
    Date of Patent: June 25, 1985
    Assignee: Beecham Group p.l.c.
    Inventors: Martin Cole, Thomas T. Howarth, Christopher Reading
  • Patent number: 4525352
    Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta. lactam antibotics against many .beta.-lactamase producing bacteria.
    Type: Grant
    Filed: December 3, 1981
    Date of Patent: June 25, 1985
    Assignee: Beecham Group p.l.c.
    Inventors: Martin Cole, Thomas T. Howarth, Christopher Reading
  • Patent number: 4427690
    Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria.
    Type: Grant
    Filed: September 24, 1976
    Date of Patent: January 24, 1984
    Assignee: Beecham Group Limited
    Inventors: Martin Cole, Thomas T. Howarth, Christopher Reading
  • Patent number: 4110165
    Abstract: A new antibacterially active agent has been isolated from Streptomyces clavuligerus. This new compound which is designated clavulanic acid has the formula (I): ##STR1## In addition to being a broad spectrum antibiotic of medium potency, clavulanic acid and its salts and esters have the ability to enhance the effectiveness of .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria.
    Type: Grant
    Filed: September 24, 1976
    Date of Patent: August 29, 1978
    Assignee: Beecham Group Limited
    Inventors: Martin Cole, Thomas T. Howarth, Christopher Reading